Regulatory

Latest News

50 | Image credit: ink drop - stock.adobe.com
BioRationality: FDA Pridefully Declares 50th Biosimilar Approval

May 20th 2024

Sarfaraz K. Niazi, PhD, congratulates the FDA on approving the 50th biosimilar, noting that there's more work to be done to expand the market.

vials AI generated | Image credit: pixardi - stock.adobe.com
Partnering for Biosimilar Security: India's Role in US Health Care Savings, Supply Chain Stability

May 9th 2024

FDA building | Image credit: JHVEPhoto - stock.adobe.com
BioRationality—FDA’s Guidance on Promotional Labeling

May 6th 2024

fda approved | Image credit: gustavofrazao - stock.adobe.com
FDA Approves High-Concentration Cyltezo

May 1st 2024

fda logo | Image credit: wladimir1804 - stock.adobe.com
FDA Approves Henlius’ Trastuzumab Biosimilar, Hercessi

April 29th 2024

Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CfB Podcast Banner
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
podcast banner
image of adalimumab biosmilar eveloped by alvotech prefilled syring
canadian flag on a mountain
CfB podcast banner

More News

© 2024 MJH Life Sciences

All rights reserved.